PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
29.47%
Positive revenue growth while 1177.HK is negative. John Neff might see a notable competitive edge here.
12.43%
Positive gross profit growth while 1177.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
-10.38%
Negative operating income growth while 1177.HK is at 142.74%. Joel Greenblatt would press for urgent turnaround measures.
-275.35%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-274.29%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-274.29%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.21%
Share reduction while 1177.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 1177.HK stands at 64.77%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
13.10%
OCF growth of 13.10% while 1177.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
21.15%
FCF growth of 21.15% while 1177.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-99.43%
Negative 10Y revenue/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.52%
Negative 5Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1840.00%
3Y CAGR of 1840.00% while 1177.HK is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
-224.03%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-150.91%
Negative 5Y OCF/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-156.03%
Negative 3Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-197.87%
Negative 10Y net income/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-124.60%
Negative 5Y net income/share CAGR while 1177.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-106.58%
Negative 3Y CAGR while 1177.HK is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
160.62%
Equity/share CAGR of 160.62% while 1177.HK is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
-99.99%
Cut dividends over 10 years while 1177.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-99.99%
Negative 5Y dividend/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 1177.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-36.26%
We have a declining book value while 1177.HK shows 7.95%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.